Intellectual Property India Publishes Patent Application for 'Antibodies Binding To Human Interleukin-6 Receptor' Filed by Mab Designs Limited

MUMBAI, India, Nov. 21 -- Intellectual Property India has published a patent application (202547084607 A) filed by Mab Designs Limited, London, on Sept. 5, for 'antibodies binding to human interleukin-6 receptor.'

Inventor(s) include Clark, Andrew; and Wijdenes, John.

The application for the patent was published on Nov. 21, under issue no. 47/2025.

According to the abstract released by the Intellectual Property India: "The present disclosure provides an antibody (or antigen binding protein) comprising at least one, preferably two, antigen binding domains that binds to human IL-6 receptor, wherein said antibody inhibits IL-6 trans signalling through the human soluble IL-6 receptor while maintaining IL-6 classical signalling through the human membrane-bound IL-6 receptor, and wherein said antibody can bind to human soluble IL-6 receptor and human membrane-bound IL-6 receptor. Compositions comprising said antibodies or antigen binding proteins are also provided, together with encoding nucleic acid molecules and expression vectors."

The patent application was internationally filed on Feb. 13, 2024, under International application No.PCT/EP2024/053654.

Disclaimer: Curated by HT Syndication.